Verve Therapeutics, Inc. (Nasdaq:VERV)
Health Care/Life Sciences • Biotechnology
CIK 1840574
Company
Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Sekar Kathiresan, Kiran Musunuru, Keith J. Joung, Issi Rozen, Sekar Kathiresan, Burt A. Adelman and Barry Ticho in 2018 and is headquartered in Boston, MA.
Address
201 Brookline Avenue
Suite 601
Boston, Massachusetts 02215
201 Brookline Avenue
Suite 601
Boston, Massachusetts 02215
Employees
255
255
Stock Info
Key Executives
Board Of Directors
Chief Executive Officer & Director Sekar Kathiresan MD |
Chairman Burt A Adelman MD |
Independent Director Sheila A Mikhail MBA, CPA |
Independent Director Alexander Gery Cumbo |
Independent Director Lonnel Coats |
Independent Director Krishna Yeshwant MD, MBA |
Independent Director Michael F MacLean |
SEC filings
Date | Form | Event |
---|---|---|
18 Nov, 2024 | SC 13G | |
12 Nov, 2024 | SC 13G/A | |
8 Nov, 2024 | SC 13G/A | |
5 Nov, 2024 | 8-K | |
5 Nov, 2024 | 10-Q | |
4 Nov, 2024 | SC 13G/A | |
22 Oct, 2024 | SC 13G/A | |
16 Oct, 2024 | SC 13G | |
9 Sep, 2024 | SC 13G/A | |
8 Aug, 2024 | 10-Q | |
8 Aug, 2024 | 8-K | |
2 Jul, 2024 | 4 | |
28 Jun, 2024 | 4 | |
28 Jun, 2024 | 8-K | |
28 Jun, 2024 | 8-K/A | |
28 Jun, 2024 | 4 | |
28 Jun, 2024 | 4 | |
28 Jun, 2024 | 4 | |
28 Jun, 2024 | 4 | |
28 Jun, 2024 | 4 | |
28 Jun, 2024 | 4 | |
28 Jun, 2024 | 4 | |
28 Jun, 2024 | 3 | |
28 Jun, 2024 | 3 | |
28 Jun, 2024 | 3 | |
27 Jun, 2024 | SC 13G | |
25 Jun, 2024 | 3 | |
25 Jun, 2024 | 4 | |
7 Jun, 2024 | 8-K | |
31 May, 2024 | 8-K | |
15 May, 2024 | 4 | |
8 May, 2024 | 8-K | |
8 May, 2024 | 10-Q | |
26 Apr, 2024 | DEF 14A | |
26 Apr, 2024 | ARS | |
26 Apr, 2024 | DEFA14A | |
3 Apr, 2024 | 4 | |
2 Apr, 2024 | 8-K | |
27 Feb, 2024 | 10-K | |
27 Feb, 2024 | S-8 | |
27 Feb, 2024 | 8-K | |
16 Feb, 2024 | 4 | |
16 Feb, 2024 | 4 | |
16 Feb, 2024 | 4 | |
16 Feb, 2024 | 4 | |
16 Feb, 2024 | 4 | |
16 Feb, 2024 | 4 | |
13 Feb, 2024 | SC 13G/A | |
9 Feb, 2024 | 5 | |
29 Jan, 2024 | SC 13G | |
29 Jan, 2024 | SC 13G/A | |
23 Jan, 2024 | SC 13G/A | |
16 Jan, 2024 | SCHEDULE 1 | |
11 Dec, 2023 | SC 13G/A | |
11 Dec, 2023 | SC 13G/A | |
5 Dec, 2023 | 4 | |
5 Dec, 2023 | 3 | |
1 Dec, 2023 | 4 | |
29 Nov, 2023 | 8-K | |
29 Nov, 2023 | 424B5 | |
28 Nov, 2023 | 424B5 | |
13 Nov, 2023 | 8-K | |
7 Nov, 2023 | 8-K | |
7 Nov, 2023 | 10-Q | |
23 Oct, 2023 | 8-K | |
19 Sep, 2023 | 4 | |
19 Sep, 2023 | 3 | |
10 Aug, 2023 | 10-Q | |
10 Aug, 2023 | 8-K | |
16 Jun, 2023 | 8-K | |
15 Jun, 2023 | 8-K | |
15 May, 2023 | 10-Q | |
15 May, 2023 | 8-K | |
28 Apr, 2023 | DEF 14A | |
28 Apr, 2023 | DEFA14A | |
28 Apr, 2023 | ARS | |
2 Mar, 2023 | 10-K | |
2 Mar, 2023 | 8-K | |
2 Mar, 2023 | S-8 | |
23 Feb, 2023 | 3 | |
17 Feb, 2023 | 8-K | |
16 Feb, 2023 | 4 | |
16 Feb, 2023 | 4 | |
16 Feb, 2023 | 4 | |
16 Feb, 2023 | 4 | |
16 Feb, 2023 | 4 | |
14 Feb, 2023 | SC 13G/A | |
14 Feb, 2023 | SC 13G/A | |
13 Feb, 2023 | SC 13G/A | |
10 Feb, 2023 | SC 13G/A | |
10 Feb, 2023 | SC 13G | |
10 Feb, 2023 | SC 13G | |
9 Feb, 2023 | SC 13G/A | |
9 Feb, 2023 | SC 13G | |
7 Feb, 2023 | SC 13G | |
6 Feb, 2023 | SC 13G/A | |
16 Dec, 2022 | 4 | |
5 Dec, 2022 | 8-K | |
2 Dec, 2022 | 4 | |
1 Dec, 2022 | 4 | |
8 Nov, 2022 | 4 | |
8 Nov, 2022 | 4 | |
7 Nov, 2022 | 10-Q | |
7 Nov, 2022 | 8-K | |
4 Nov, 2022 | 4 | |
4 Nov, 2022 | 4 | |
2 Nov, 2022 | 4 | |
2 Nov, 2022 | 4 | |
1 Nov, 2022 | 4 | |
5 Oct, 2022 | 4 | |
27 Sep, 2022 | 4 | |
23 Sep, 2022 | S-3ASR | |
29 Aug, 2022 | 4 | |
11 Aug, 2022 | 4 | |
10 Aug, 2022 | SC 13G/A | |
9 Aug, 2022 | 8-K | |
9 Aug, 2022 | 4 | |
9 Aug, 2022 | 3 | |
9 Aug, 2022 | 10-Q | |
28 Jul, 2022 | 4 | |
22 Jul, 2022 | 4 | |
21 Jul, 2022 | 8-K | |
21 Jul, 2022 | 4 | |
21 Jul, 2022 | 8-K | |
21 Jul, 2022 | 424B5 | |
20 Jul, 2022 | 8-K | |
20 Jul, 2022 | 424B5 | |
15 Jul, 2022 | 4 | |
15 Jul, 2022 | 4 | |
14 Jul, 2022 | 4 | |
12 Jul, 2022 | 8-K | |
12 Jul, 2022 | EFFECT | |
8 Jul, 2022 | CORRESP | |
7 Jul, 2022 | 8-K | |
7 Jul, 2022 | UPLOAD | |
6 Jul, 2022 | 4 | |
1 Jul, 2022 | 4 | |
1 Jul, 2022 | S-3 | |
13 Jun, 2022 | 4 | |
13 Jun, 2022 | 4 | |
13 Jun, 2022 | 4 | |
13 Jun, 2022 | 4 | |
13 Jun, 2022 | 4 | |
13 Jun, 2022 | 3 | |
13 Jun, 2022 | 8-K | |
13 Jun, 2022 | 4 | |
13 May, 2022 | 4 | |
10 May, 2022 | 8-K | |
10 May, 2022 | 10-Q | |
29 Apr, 2022 | DEFA14A | |
29 Apr, 2022 | DEF 14A | |
22 Mar, 2022 | 4 | |
17 Mar, 2022 | 4 | |
14 Mar, 2022 | S-8 | |
14 Mar, 2022 | 10-K | |
14 Mar, 2022 | 8-K | |
11 Mar, 2022 | 4 | |
15 Feb, 2022 | 4 | |
15 Feb, 2022 | 4 | |
15 Feb, 2022 | 4 | |
15 Feb, 2022 | 4 | |
14 Feb, 2022 | SC 13G | |
14 Feb, 2022 | SC 13G/A | |
11 Feb, 2022 | 4 | |
9 Feb, 2022 | SC 13G | |
9 Feb, 2022 | SC 13G/A | |
4 Feb, 2022 | SC 13G/A | |
4 Feb, 2022 | SC 13G | |
3 Feb, 2022 | 4 | |
28 Jan, 2022 | 4 | |
24 Jan, 2022 | SC 13G | |
6 Jan, 2022 | 4 | |
29 Dec, 2021 | 4 | |
28 Dec, 2021 | SC 13G/A | |
28 Dec, 2021 | 3 | |
27 Dec, 2021 | 4 | |
27 Dec, 2021 | 4 | |
17 Dec, 2021 | 4 | |
6 Dec, 2021 | 4 | |
6 Dec, 2021 | 4 | |
30 Nov, 2021 | 3 | |
30 Nov, 2021 | 4 | |
29 Nov, 2021 | 8-K | |
10 Nov, 2021 | 8-K | |
10 Nov, 2021 | 10-Q | |
24 Aug, 2021 | 8-K | |
16 Aug, 2021 | 10-Q/A | |
12 Aug, 2021 | 10-Q | |
12 Aug, 2021 | 8-K | |
28 Jun, 2021 | SC 13G | |
23 Jun, 2021 | 4 | |
23 Jun, 2021 | 4 | |
23 Jun, 2021 | 4 | |
23 Jun, 2021 | 4 | |
23 Jun, 2021 | 4 | |
23 Jun, 2021 | 4 | |
23 Jun, 2021 | SC 13G | |
23 Jun, 2021 | SC 13G | |
22 Jun, 2021 | 4 | |
22 Jun, 2021 | 4 | |
22 Jun, 2021 | 4 | |
22 Jun, 2021 | 4 | |
22 Jun, 2021 | 4 | |
22 Jun, 2021 | 4 | |
22 Jun, 2021 | 4 | |
22 Jun, 2021 | 4 | |
22 Jun, 2021 | 4 | |
21 Jun, 2021 | 4 | |
21 Jun, 2021 | 8-K | |
21 Jun, 2021 | 4 | |
21 Jun, 2021 | 4 | |
21 Jun, 2021 | 4 | |
21 Jun, 2021 | 4 | |
17 Jun, 2021 | S-8 | |
17 Jun, 2021 | 424B4 | IPO completed |
16 Jun, 2021 | S-1MEF | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | EFFECT | |
16 Jun, 2021 | SEC STAFF | |
15 Jun, 2021 | CERT | |
14 Jun, 2021 | S-1/A | |
14 Jun, 2021 | CORRESP | |
14 Jun, 2021 | CORRESP | |
11 Jun, 2021 | 8-A12B | |
4 Jun, 2021 | CORRESP | |
28 May, 2021 | CORRESP | |
28 May, 2021 | S-1 | |
13 May, 2021 | SEC STAFF | |
13 May, 2021 | UPLOAD | |
16 Apr, 2021 | DRS | |
22 Jan, 2021 | D |
Last update:2024-03-06 13:29:07.332068
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.